Showing results (11-20 of 661) with videos related to
Sort By:
Pageof 67
Advances in Therapy|January 4, 2014
Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD)Iliana Doycheva, Rohit LoombaClinical and Molecular Hepatology|July 15, 2026
Steatotic Liver Disease: Non-Invasive Assessment and Biomarkers Across MASLD, MetALD and ALDMonica Tincopa, Rohit LoombaTherapeutic Advances in Gastroenterology|July 2, 2019
Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic interventionMarialena Mouzaki, Rohit LoombaCureus|July 17, 2015
Ibuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of AdministrationRohit Loomba, Karan NijhawanCurrent Opinion in Gastroenterology|April 11, 2014
State of the art: treatment of nonalcoholic steatohepatitisMichelle Pearlman, Rohit LoombaCurrent Opinion in Gastroenterology|May 5, 2023
Advances in the genetics of nonalcoholic fatty liver diseaseVeeral Ajmera, Rohit LoombaMolecular Metabolism|January 18, 2021
Imaging biomarkers of NAFLD, NASH, and fibrosisVeeral Ajmera, Rohit LoombaGynecologic Oncology Reports|July 22, 2024
Challenges in PARP inhibitor therapy: A case of Olaparib-induced liver injury and successful rechallenge with NiraparibKai Zhu, Yvette Drew, Saumya JayakumarHepatology (Baltimore, Md.)|April 4, 2023
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCCSuzanne R Sharpton, Rohit LoombaNature Reviews. Gastroenterology & Hepatology|September 18, 2013
The global NAFLD epidemicRohit Loomba, Arun J SanyalPageof 67